Sonographic Features of Rectus Femoris Muscle in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease and Their Correlation with Body Composition Parameters and Muscle Strength: Results of a Single-Center Cross-Sectional Study

被引:0
|
作者
Sheptulina, Anna F. [1 ]
Yafarova, Adel A. [1 ]
Mamutova, Elvira M. [1 ]
Drapkina, Oxana M. [1 ,2 ]
机构
[1] Natl Med Res Ctr Therapy & Prevent Med, Dept Fundamental & Appl Aspects Obes, Moscow 101990, Russia
[2] AI Evdokimov Moscow State Univ Med & Dent, Dept Therapy & Prevent Med, Moscow 127473, Russia
基金
俄罗斯科学基金会;
关键词
ultrasound; skeletal muscles; dual-energy X-ray absorptiometry; bioimpedance analysis; metabolic dysfunction-associated steatotic liver disease; BONE-MINERAL DENSITY; PHYSICAL-ACTIVITY; SARCOPENIC OBESITY; OLDER-ADULTS; ULTRASOUND; DISCORDANCE; RELIABILITY; DIAGNOSIS; ELASTOGRAPHY; DEFINITION;
D O I
10.3390/biomedicines12081684
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to describe sonographic features of rectus femoris muscle (RFM) in patients with metabolic dysfunction-associated fatty liver disease (MASLD) and their correlation with body composition parameters and muscle strength. A total of 67 patients with MASLD underwent dual-energy X-ray absorptiometry (DEXA), bioimpedance analysis (BIA), muscle strength measurement (grip strength [GS] and chair stand test [CST]), and ultrasound (US) investigation of the RFM in the dominant thigh using a 4 to 18 MHz linear probe. MASLD patients exhibited increased RFM echogenicity, possibly due to fatty infiltration. We confirmed that the greater the subcutaneous fat thickness, the smaller was the muscle mass (p < 0.001), and the lower was the muscle strength (p < 0.001 for GS and p = 0.002 for CST). On the contrary, the greater the anteroposterior diameter (APD) of RFM, the higher was the muscle mass (p < 0.001), and the greater was the muscle strength (p < 0.001 for GS and p = 0.007 for CST). In addition, APD of the RFM and stiffness of RFM exhibited direct correlation with bone mineral density values of the lumbar spine (p = 0.005 for both GS and CST). We concluded that US investigation of the RFM in the dominant thigh can be helpful in identifying MASLD patients at a high risk of musculoskeletal disorders given repeated point-of-care clinical evaluations.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients
    Binet, Quentin
    Loumaye, Audrey
    Hermans, Michel P.
    Lanthier, Nicolas
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (06) : 1377 - 1386
  • [32] Association between the traditional Chinese medicine constitution and metabolic dysfunction-associated fatty liver disease in older people: A cross-sectional study
    Shen, Tianran
    Wang, Shupei
    Wang, Zhihao
    Jia, Hanlu
    Wei, Yuan
    Li, Yu
    Zheng, Qiutong
    Li, Yuting
    Pan, Luanzhao
    Chen, Qingsong
    HELIYON, 2024, 10 (03)
  • [33] Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study [Letter]
    Han, Jiaxia
    Lu, Wensheng
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2407 - 2408
  • [34] Association between composite dietary antioxidant index and metabolic dysfunction-associated fatty liver disease: a cross-sectional study from NHANES
    Dong, Jia-Xin
    Jiang, Li-Li
    Liu, Yan-Peng
    Zheng, Ai-Xi
    BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [35] ASSOCIATIONS BETWEEN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE AND ABDOMINAL PAIN: A SINGLE-CENTER RETROSPECTIVE STUDY
    Waldenmaier, George
    Bhavsar-Burke, Indira
    Kubiliun, Maddie
    HEPATOLOGY, 2024, 80 : S813 - S813
  • [36] Risk factors for decreased bone mineral density in patients with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study at a health examination center
    Yokoyama, Shinya
    Honda, Takashi
    Ishizu, Yoji
    Imai, Norihiro
    Ito, Takanori
    Yamamoto, Kenta
    Mizuno, Kazuyuki
    Kojima, Tetsuhito
    Kariya, Naoyoshi
    Nakamura, Masanao
    Kawashima, Hiroki
    CLINICAL NUTRITION, 2024, 43 (06) : 1425 - 1432
  • [37] INVESTIGATION OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN AN UNDERINSURED AND LOWSOCIOECONOMIC RESIDENT CLINIC; A CROSS-SECTIONAL STUDY
    Weinstein, David
    Belohlavek, David
    Imas, Polina
    Ward, Elizabeth
    Zolotarevsky, Mitchelle
    GASTROENTEROLOGY, 2024, 166 (05) : S1661 - S1661
  • [38] Association between cardiovascular health and metabolic dysfunction-associated steatotic liver disease: a nationwide cross-sectional study
    Huang, Lian-Zhen
    Ni, Ze-Bin
    Huang, Wei-Feng
    Sheng, Li-Ping
    Wang, Yan-Qing
    Zhang, Jin-Yan
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2025, 44 (01)
  • [39] Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study
    Qiu, Xin
    Shen, Shuang
    Jiang, Nizhen
    Lu, Donghong
    Feng, Yifei
    Yang, Guodong
    Xiang, Bangde
    FRONTIERS IN NUTRITION, 2025, 12
  • [40] Morphological Parameters in Quadriceps Muscle Were Associated with Clinical Features and Muscle Strength of Women with Rheumatoid Arthritis: A Cross-Sectional Study
    dos Santos, Leonardo Peterson
    do Espirito Santo, Rafaela Cavalheiro
    Pena, Emerson
    Doria, Lucas Denardi
    Hax, Vanessa
    Brenol, Claiton Viegas
    Monticielo, Odirlei Andre
    Chakr, Rafael Mendonca da Silva
    Xavier, Ricardo Machado
    DIAGNOSTICS, 2021, 11 (11)